Dolan, Michael-John
Therrien, Martine http://orcid.org/0000-0003-3150-4052
Jereb, Saša
Kamath, Tushar
Gazestani, Vahid
Atkeson, Trevor
Marsh, Samuel E. http://orcid.org/0000-0002-3012-6945
Goeva, Aleksandrina
Lojek, Neal M.
Murphy, Sarah
White, Cassandra M. http://orcid.org/0000-0002-6697-4321
Joung, Julia
Liu, Bingxu http://orcid.org/0000-0002-3661-3410
Limone, Francesco
Eggan, Kevin
Hacohen, Nir http://orcid.org/0000-0002-2349-2656
Bernstein, Bradley E.
Glass, Christopher K. http://orcid.org/0000-0003-4344-3592
Leinonen, Ville
Blurton-Jones, Mathew http://orcid.org/0000-0002-7770-7157
Zhang, Feng http://orcid.org/0000-0003-0178-7995
Epstein, Charles B. http://orcid.org/0000-0001-8358-8345
Macosko, Evan Z. http://orcid.org/0000-0002-2794-5165
Stevens, Beth http://orcid.org/0000-0003-4226-1201
Funding for this research was provided by:
Alzheimer’s Association (ADSF-21-831114-C)
Life Sciences Research Foundation
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
Article History
Received: 28 April 2022
Accepted: 9 June 2023
First Online: 27 July 2023
Competing interests
: K.E. is cofounder of Q-State Biosciences, Quralis and Enclear Therapies, and is group vice president at BioMarin Pharmaceutical. M.B.-J. is a coinventor of patent application WO/2018/160496, related to the differentiation of pluripotent stem cells into microglia, and cofounder of NovoGlia Inc. B.S. serves on the SAB and is also a minor shareholder in Annexon Biosciences and Neumora Therapeutics.